Suzano S.A. (SUZ) Form 6-K — May 28, 2026

Suzano S.A. announced that it has obtained all necessary antitrust regulatory approvals for its joint venture with Kimberly-Clark Corporation. This milestone clears a major condition precedent for the acquisition of a 51% equity interest in a new Dutch entity holding K-C's tissue assets outside North America. The transaction remains subject to the completion of Kimberly-Clark’s corporate reorganization across multiple global regions.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.